Biotech Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a Capsid Inhibitor July 20, 2022
Biotech Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022 July 20, 2022
Biotech Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies July 20, 2022
Biotech Aquestive Therapeutics to Report Second Quarter 2022 Financial Results and Recent Business Highlights on August 2 and Host Conference Call on August 3 at 8:00 a.m. ET July 20, 2022
Biotech Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome July 20, 2022
Biotech Adial Pharmaceuticals Announces Topline Results For Onward(TM) Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder July 20, 2022
Biotech Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress July 20, 2022
Biotech Capricor Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy July 19, 2022
Search
biotech companies
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 19, 2022
